RS1-PDK1 inhibitor

CAS No. 1643958-85-3

RS1-PDK1 inhibitor( —— )

Catalog No. M34021 CAS No. 1643958-85-3

RS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 655 In Stock
10MG 924 In Stock
25MG 1359 In Stock
50MG 1795 In Stock
100MG 2446 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RS1-PDK1 inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    RS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.
  • Description
    RS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PDK
  • Recptor
    PDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1643958-85-3
  • Formula Weight
    380.89
  • Molecular Formula
    C15H9ClN2O2S3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(NC1=NC=2C(S1)=CC(Cl)=CC2)(=O)(=O)C=3C=4C(SC3)=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 6-Bromo-4-methoxypyr...

    6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.

  • PS 210

    PS 210 is a potent, specific activator of PDK1 that target the PIF-binding pocket of PDK1.

  • KPLH1130

    KPLH1130 improves glucose tolerance in HFD-fed mice.?KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.